Related Experiment Video
Updated: Dec 25, 2025
09:21
Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
12.4K
Update on Treatment of Acute Ischemic Stroke
Continuum (Minneapolis, Minn.)
|April 1, 2020
Summary
Recent advancements expand reperfusion treatment for acute ischemic stroke. Carefully selected patients can now receive emergency reperfusion therapy up to 24 hours after symptom onset, improving outcomes.
Area of Science:
- Neurology
- Cerebrovascular Diseases
Background:
- Acute ischemic stroke requires timely intervention.
- Reperfusion therapy is critical for improving outcomes.
Purpose of the Study:
- To provide an update on the current treatment of acute ischemic stroke.
- To emphasize indications for reperfusion therapy.
Main Methods:
- Review of recent randomized controlled trials.
- Analysis of expanded indications for reperfusion therapy.
Main Results:
- Established indications for intravenous thrombolysis (within 4.5 hours) and mechanical thrombectomy (within 6 hours).
- New indications for reperfusion in wake-up or delayed presentation strokes (up to 24 hours).
- Perfusion imaging or MRI is crucial for patient selection in extended windows.
Conclusions:
- Timely and successful reperfusion is the most effective treatment.
- Recent evidence supports expanded time windows for reperfusion in selected patients.
Related Concept Videos
01:28Acute Coronary Syndrome IV: Interprofessional Care
172
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
172
01:29Venous Thrombosis III: Interprofessional Care
220
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
220
01:30Acute Coronary Syndrome I: Introduction
593
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
593
01:27Peripheral Artery Disease III: Interprofessional Care
182
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
182
01:27Coronary Artery Disease V: Interprofessional Care
182
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
182
01:22Alzheimer's Disease: Treatment
697
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
697